<DOC>
	<DOCNO>NCT00564668</DOCNO>
	<brief_summary>This trial conduct Japan . The aim trial investigate safety efficacy NN2000-Mix30 produce NN2000 process compare NN-X14Mix30 produce current process Japanese subject type 2 diabetes .</brief_summary>
	<brief_title>Comparison Biphasic Insulin Aspart Produced NN2000 Process Current Process Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Subjects type 2 diabetes Subjects insulin treatment least 24 week Current treatment premixed biphasic human insulin preparation least 12 week HbA1c lesser equal 11.0 % Recurrent severe hypoglycaemia Proliferative retinopathy maculopathy require acute treatment Impaired renal function Cardiac diseases Uncontrolled hypertension Subjects know malignant tumour Total daily insulin dose great equal 100 IU</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>